Kodak will manufacture generics for USA
The US government has reached an agreement with Kodak about the production of drugs for the American market. For organization of pharmaceutical production, the company will receive a credit in the amount of 765 million dollars, writes Fortune.
It is expected that the production of drugs in the future will amount to 30-40% of the business by Kodak. As expected, the company will be able to provide 25% of all played active pharmaceutical ingredients in the U.S. market. The production will be organized in the state of new York.
